1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:OCT and VH-IVUS findings for corresponding lesions
OCT VH-IVUS P Value Prestenting (n = 34) Thrombus, No. (%) 15 (44.1) 1 (2.9) <.001 Neovascularization, No. (%) 13 (38.2) 0 (0) <.001 Ulceration, No. (%) 3 (8.8) 0 (0) .24 Calcification, No. (%) 13 (38.2) 34 (100)a <.001 Lipid, No. (%) 28 (82.4) 30 (88.2)b .73 Poststenting (n = 34) Plaque protrusion, No. (%) 6 (17.6) 0 (0) .032